-+ 0.00%
-+ 0.00%
-+ 0.00%

Nautilus Biotechnology Q1 EPS $(0.12) Beats $(0.17) Estimate

Benzinga·04/28/2026 10:11:29
Listen to the news
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.17) by 25 percent. This is a 7.69 percent increase over losses of $(0.13) per share from the same period last year.